Correlation Between Dyne Therapeutics and Bioatla
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Bioatla at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Bioatla into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Bioatla, you can compare the effects of market volatilities on Dyne Therapeutics and Bioatla and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Bioatla. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Bioatla.
Diversification Opportunities for Dyne Therapeutics and Bioatla
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dyne and Bioatla is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Bioatla in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bioatla and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Bioatla. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bioatla has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Bioatla go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Bioatla
Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 0.69 times more return on investment than Bioatla. However, Dyne Therapeutics is 1.44 times less risky than Bioatla. It trades about -0.02 of its potential returns per unit of risk. Bioatla is currently generating about -0.09 per unit of risk. If you would invest 3,110 in Dyne Therapeutics on August 25, 2024 and sell it today you would lose (141.00) from holding Dyne Therapeutics or give up 4.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Bioatla
Performance |
| Timeline |
| Dyne Therapeutics |
| Bioatla |
Dyne Therapeutics and Bioatla Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Bioatla
The main advantage of trading using opposite Dyne Therapeutics and Bioatla positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Bioatla can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioatla will offset losses from the drop in Bioatla's long position.| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
| Bioatla vs. Pmv Pharmaceuticals | Bioatla vs. C4 Therapeutics | Bioatla vs. Nautilus Biotechnology | Bioatla vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |